• By Michael Borella —

    USPTO SealThe second part of the patent-eligibility test of Alice Corp. v. CLS Bank Int'l involves an inquiry into whether certain elements of a claim directed to an unpatentable judicial exception are "well-understood, routine, and conventional."  If this is the case, the claim fails to meet the requirements of 35 U.S.C. § 101.  If not, the claim clears the § 101 hurdle.  Since Alice, this determination has been largely treated as a matter of law.

    But recently, in Berkheimer vs. HP Inc., the Federal Circuit stated:

    The question of whether a claim element or combination of elements is well-understood, routine and conventional to a skilled artisan in the relevant field is a question of fact.  Any fact . . . that is pertinent to the invalidity conclusion must be proven by clear and convincing evidence.  Like indefiniteness, enablement, or obviousness, whether a claim recites patent eligible subject matter is a question of law which may contain underlying facts. 

    (Emphasis added.)

    The Court noted that some § 101 disputes may be resolved as a matter of law when there is no material issue of fact regarding whether one or more claim elements, or combination thereof, are well-understood, routine, or conventional to a person of ordinary skill in the art.  Based on this reasoning, HP's summary judgment motion for ineligibility was reversed and remanded to the District Court for further proceedings.  The Court reiterated this position a few days later in Aatrix Software Inc. v. Green Shades Software, Inc. and three times since then in non-precedential decisions.

    On April 19, the U.S. Patent and Trademark Office (USPTO) published a memorandum providing updated § 101 examination guidance that takes the Berkheimer rule into account.  This memo was widely anticipated given that Berkheimer is viewed as one of the more significant § 101 decisions in recent history, and also because at least some Patent Trial and Appeal Board (PTAB) panels have stated that the case's holding does not apply to their review of patent-eligibility rejections from examiners (see, e.g., Decision on Request for Rehearing in Ex parte Daniel R. Swanson Sr.). 

    In the memo, the Office begins by reviewing the Berkheimer case and acknowledging its importance.  The Office writes:  "[w]hile the Berkheimer decision does not change the basic subject matter eligibility framework as set forth in MPEP § 2106, it does provide clarification as to the inquiry into whether an additional element (or combination of additional elements) represents well-understood, routine, conventional activity."

    The Office goes on to specify how the case impacts examination procedure.  Notably, when applying the second part of the Alice test, an examiner should not find that an additional element is well-understood, routine or conventional unless the examiner can expressly support (in writing) one of the following four rationales.

    1. "A citation to an express statement in the specification or to a statement made by an applicant during prosecution that demonstrates the well-understood, routine, conventional nature of the additional element(s)."  But, an element is not well-understood, routine, or conventional if "the specification is silent with respect to describing such element."

    2. "A citation to one or more [court decisions] noting the well-understood, routine, conventional nature of the additional element(s)."

    3. "A citation to a publication that demonstrates the well-understood, routine, conventional nature of the additional element(s)."  This does not include all publications that could qualify as prior art under § 102, however.  Particularly, "the description of the additional elements in the publication would need to demonstrate that the additional elements are widely prevalent or in common use in the relevant field, comparable to the types of activity or elements that are so well-known that they do not need to be described in detail in a patent application to satisfy 35 U.S.C. § 112(a)."

    4. "A statement that the examiner is taking official notice of the well-understood, routine, conventional nature of the additional element(s)."  An examiner should only take this option "when the examiner is certain, based upon his or her personal knowledge, that . . . the additional elements are widely prevalent or in common use in the relevant field, comparable to the types of activity or elements that are so well-known that they do not need to be described in detail in a patent application to satisfy 35 U.S.C. § 112(a)."  Of course, the applicant can challenge the official notice following the procedures of MPEP § 2144.03, which should result in the examiner having to rely on one of the first three rationales.

    This guidance certain is welcome.  Conclusory reasoning is not uncommon in § 101 rejections and examiners who follow this guidance will be less likely to rely upon such a technique.  But there are reasons why we might not expect this guidance to result in a substantive change in examination.

    The second rationale requires a citation to case law indicating that a claimed element is similar to something found to be well-understood, routine, or conventional by the Supreme Court or Federal Circuit.  There are many such decisions, numerous ones of which involve conclusory reasoning themselves regarding additional elements.  Also, there is little discussion in the memo as to how examiner as supposed to consider whether a combination of additional elements constitutes significantly more.  Thus, use of this rationale might not, in truth, avoid the problem that the USPTO is trying to solve.

    Additionally, the USPTO's new emphasis on the second part of Alice may incentivize examiners to lump more elements under the first part, leaving a small number of simple additional elements that can be quickly dismissed as well-understood, routine, or conventional under the second part (i.e., using the second rationale above).  For instance, consider this claim from the USPTO's Example 34:

    1.  A content filtering system for filtering content retrieved from an Internet computer network by individual controlled access network accounts, said filtering system comprising:
        a local client computer generating network access requests for said individual controlled access network accounts; at least one filtering scheme;
        a plurality of sets of logical filtering elements; and
        a remote ISP server coupled to said client computer and said Internet computer network, said ISP server associating each said network account to at least one filtering scheme and at least one set of filtering elements, said ISP server further receiving said network access requests from said client computer and executing said associated filtering scheme utilizing said associated set of logical filtering elements.

    The USPTO stated that this claim is eligible.  Nonetheless, an examiner may still review the claim elements piecemeal.  For example, the examiner might contend that the claim is directed to the abstract idea of content filtering, and that the additional elements of a local client computer, remote ISP server, and computer network are well-understood, routine, and conventional.  By grouping as many elements as possible under the looser rubric of part one, it is easier to justify, even under the new guidance, that a claim is ineligible.

    In short, the memo gives applicants a few more tools for rebutting examiners, but the scourge of § 101 rejections with little or no supportive reasoning is far from over.

  • By Antony Craggs* —

    EPOThe therapeutic methods exclusion is often problematic to navigate.  In T 0699/12, the Technical Board of Appeal (TBA) of the European Patent Office (EPO) has provided some useful guidance on its application.  In an opposition before the Opposition Division, the division held that the patent in suit (which was for a method for performing in vivo dosimetry) was invalid pursuant to Art 53(c) of the European Patent Convention (EPC).

    Art. 53(c) of the EPC states:  "European patents shall not be granted in respect of:  . . . methods for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body . . . ."

    On appeal the Technical Board of Appeal, considering the effect of this provision, referred to decision G 01/04 and explained that it ". . . clarified that a method claim falls under the prohibition of patenting methods for treatment by therapy or surgery under Art. 53(c) EPC if it comprises or encompasses at least one feature defining a physical activity of action that constitutes a method step for treatment of a human or animal body by surgery or therapy . . . ."

    It concluded that Art 53(c), therefore, did not exclude methods from patent protection that are used during a therapeutic or surgical treatment of a human or animal body, but methods that are therapeutic or surgical treatments of a human or animal body.

    Applying this to claim 1 of the patentee's main request, this read as follows:

    1. Method for enabling quantification of dose delivery in radiotherapy treatment, characterized in that it comprises the steps of:
        - irradiation of a phantom following a treatment
    plan of a patient,
        - measurement of the irradiation in said phantom,
        - collecting information regarding the irradiation by information means arranged between the phantom and the radiation source, wherein said measurements are divided in time-intervals, and
        - analysing the measurements for obtaining information regarding the relationship between the measurements in the phantom and measurements in the information means between the phantom and the treatment source at each time-interval,
        - using said relationship information during verification of the treatment of the patient.

    The patent specification further explained that the "invention is thereby a method to calibrate the detectors to be used in vivo (during treatment) in a time-efficient and accurate way to achieve high quality, reliable dose measurements during treatment".

    The Technical Board of Appeal concluded that the wording of claim 1 did not include any step that could be considered as being of surgical or therapeutic nature, since no actual irradiating step was claimed.  It reasoned that the "verification" (namely, 'quantification of the dose delivery' of the treatment) had no therapeutic or surgical effects as such.  Rather, it only determined (verified) the radiation dose during a treatment.

    Expressed another way, the claimed method only concerned the technical operation of a device (the radiation/ treatment source and the information means/detectors) without any functional link to the effects of the device on the body.

    * Mr. Craggs is a patent attorney with D Young & Co

    This article was reprinted with permission from D Young & Co.

  • CalendarApril 23-24, 2018 – Paragraph IV Disputes conference (American Conference Institute) – New York, NY

    April 24, 2018 – "Trade Secrets Update 2018: Year Two of the DTSA" (McDonnell Boehnen Hulbert & Berghoff LLP) – 10:00 am to 11:15 am (CT)

    April 26, 2018 – "Patent Eligibility, Duty to Disclose and More: USPTO Manual of Patent Examining Procedure New Guidance" (Strafford) – 1:00 to 2:30 pm (EDT)

    April 27, 2018 – Ethics in the Practice of Intellectual Property Law (John Marshall Law School Center for Intellectual Property, Information & Privacy Law) – 12:30 to 5:15 pm, Chicago, IL

    May 1, 2018 – "Patent Inventorship: Best Practices for Determination and Correction — Distinguishing Between Inventor and Contributor; Navigating Joint Inventorship, Disclosure of Ownership, Real Party in Interest" (Strafford) – 1:00 to 2:30 pm (EDT)

    May 2, 2018 – "Recent Developments in Double Patenting: ODP Challenges and Considerations" (The Knowledge Group) – 12:00 to 1:30 pm (ET)

    May 3, 2018 – "Patent Ownership Rights: Structuring Assignment and Employment Contracts — Key Provisions, Implications for Litigation, Recent Court Treatment" (Strafford) – 1:00 to 2:30 pm (EDT)

    May 3, 2017 – "The Very Essence of Romance is Uncertainty" (Intellectual Property Owners Association European Practice Committee) – Amsterdam, Netherlands

    May 3, 2018 – "The Evolving State of Sovereign Immunity Before the Patent Trial and Appeal Board" (Technology Transfer Tactics) – 1:00 to 2:00 pm (ET)

    May 8, 2018 – Symposium on Intellectual Property (George Washington University Law School, Pillsbury, NERA Economic Consulting, and Mayer Brown) – Washington, DC

    May 8, 2018 – "Intellectual Property Valuation and Damages: Nuts and Bolts in 2018" (The Knowledge Group) – 12:00 to 1:30 pm (ET)

    May 9, 2018 – "Supplemental Examination Requests: Benefits and Limitations, Strategic Use — Assessing Enforceability of Patent Portfolios, Evaluating the High Burden" (Strafford) – 1:00 to 2:30 pm (EDT)

    May 8-10, 2018 – Patent Fundamentals Bootcamp 2018: An Introduction to Patent Drafting, Prosecution, and Litigation (Practising Law Institute) – Chicago, IL

    June 13-15, 2018 – Patent Fundamentals Bootcamp 2018: An Introduction to Patent Drafting, Prosecution, and Litigation (Practising Law Institute) – New York, NY

    June 25-27, 2018 – Summit on Biosimilars (American Conference Institute) – New York, NY

    July 18-20, 2018 – Patent Fundamentals Bootcamp 2018: An Introduction to Patent Drafting, Prosecution, and Litigation (Practising Law Institute) – San Francisco, CA

  • PLI #1Practising Law Institute (PLI) will be holding its Patent Fundamentals Bootcamp 2018: An Introduction to Patent Drafting, Prosecution, and Litigation on May 8-10, 2018 in Chicago, IL, on June 13-15, 2018 in New York, NY, and on July 18-20, 2018 in San Francisco, CA.  The three-day program, which is directed to patent prosecuting and litigating attorneys and patent agents with or without a Patent Office registration number or little patent experience, will focus on teaching the basics of claim drafting, patent application preparation and prosecution, as well as a review of recent developments in the law.  A litigator's perspective is also presented to show how drafting and prosecution can influence the development, and often the outcome, of subsequent patent litigation.  The seminar will feature lectures in the morning followed by small clinic sessions in the afternoon, with day 1 focusing on invention disclosures and patent preparation, day 2 on prosecution and issuance, and day 3 on litigation/claim analysis.  Lectures will explain:

    • Learn how to prepare a patent application that satisfies the statutory requirements for patentability and distinctly claims the subject matter which the applicant regards as the invention with an eye towards successful prosecution and enforcement
    • Understand how to prosecute an application to obtain allowance of an enforceable patent
    • Find out how to interview an Examiner
    • Discover effective uses of reissues, reexamination supplemental examinations, inter partes review, post-grant review and other post-issuance proceedings
    • Determine best practices to anticipate patent litigation issues during the patent prosecution process
    • Get helpful approaches on patent opinion drafting
    • Learn how to prepare infringement/invalidity claim charts for litigation

    PLI faculty will offer presentations on the following topics:

    • Initial Steps of a Patent Invention Disclosure
    • An Overview of Claim Drafting and Preparation of a Patent Application
    • The Basics of Patent Claim Drafting
    • Review of Patent Model Claims
    • An Overview of Patent Prosecution
    • Conducting the Examiner Interview
    • Patent Prosecutor Ethics
    • Patent Litigation Issues
    • Patent Claim Chart Review

    A program schedule and list of speakers for each of the locations can be found here.  Patent Docs authors Kevin Noonan (Chicago co-chair) and Donald Zuhn will be presenting on day 1 at the Chicago seminar.

    The registration fee for the conference is $2,195.  Those interested in registering for the conference can do so at the PLI website.

  • George Washington University Law SchoolThe George Washington University Law School (with Pillsbury, NERA Economic Consulting, and Mayer Brown) will be holding its annual Symposium on Intellectual Property on May 8, 2018 at The George Washington University Law School, 2000 H Street NW, Washington, DC.  The Symposium will offer presentations on the following topics:

    • Keynote Address — Hon. David Ruschke, Chief Administrative Patent Judge, U.S. Patent and Trademark Office
    • Hot Topics at the Patent Trial and Appeal Board
    • Effective Appellate Advocacy at the Federal Circuit
    • Valuation of Patent Portfolios
    • Current Issues Facing In-House Patent Lawyers

    Additional information about the Symposium, including a program and list of speakers can be found here.  A cocktail reception will take place following the Symposium.

    Registration for the symposium is complimentary.  Those interested in registering for the Symposium can do so here.

  • Technology Transfer Tactics will be offering a webinar entitled "The Evolving State of Sovereign Immunity Before the Patent Trial and Appeal Board" on May 3, 2018 from 1:00 to 2:00 pm (ET). Tyson Benson of Harness, Dickey & Pierce, PLC will address the following topics:

    • Recent decisions handed down by the Patent Trial Appeal Board, including decisions that:
        – held a university entity waived its sovereign immunity by filing a patent infringement case in district court
        – denied trial sovereign immunity for lack of establishment that trial sovereign immunity should be applied in PTAB proceedings
    • What technology managers should be doing to protect their patent portfolio during this ever-evolving subject
    • Potential impact on licensing and patent value
    • Updates from pending cases, new decisions, and/or arguments
    • Potential impact of the newly introduced Preserving Access to Cost Effective Drugs (PACED) Act

    The registration fee for the webinar is $197. Those interested in registering for the webinar, can do so here.

    Technology Transfer Tactics

  • Strafford #1Strafford will be offering a webinar entitled "Supplemental Examination Requests: Benefits and Limitations, Strategic Use — Assessing Enforceability of Patent Portfolios, Evaluating the High Burden" on May 9, 2018 from 1:00 to 2:30 pm (EDT).  Thomas L. Irving, Amanda K. Murphy, and Jennifer S. Swan of Finnegan Henderson Farabow Garrett & Dunner will guide patent counsel on supplemental examination requests generally and specific to chemical patents, examine the supplemental examination successes and its limitations, and provide insight on the strategic use of supplemental examinations.  The webinar will review the following issues:

    • How should counsel balance the benefits and limitations of supplemental examination before filing a request?
    • What are the burdens for patent owners considering a request for supplemental examination?
    • How can pharma patent owners leverage the patent system along with the drug approval process?
    • What is the impact on supplemental examination?

    The registration fee for the webcast is $297.  Those interested in registering for the webinar, can do so here.

  • The Knowledge GroupThe Knowledge Group will offer a webcast entitled "Intellectual Property Valuation and Damages: Nuts and Bolts in 2018" on May 8, 2018 from 12:00 to 1:30 pm (ET).  David Leathers of Alvarez & Marsal, Peter Hess of Analysis Group, and Brian Dies of Hoffman Alvary & Company LLC will address the following topics:

    • IP Valuation Methods: Recent Trends and Developments
    • Estimating Damages in IP Litigation
    • Notable Court Rulings
    • Overcoming Challenges
    • Maximizing IP Asset's Value

    The registration fee for the webcast is $99.  Those interested in registering for the webinar can do so here.

  • By Josh Rich —

    ABAOn April 17th, the American Bar Association provided a formal opinion regarding the requirement that attorneys disclose errors to clients.  Its opinion was based on Rule 1.4 of the Model Rules of Professional Conduct, which governs communications with clients.  The ABA concluded that attorneys have a duty to disclose material errors to clients, but no duty to disclose errors to former clients.  In this context, an error is material if a disinterested attorney would believe that the error would likely cause harm or prejudice to the client, or that the error would reasonably cause a client to consider terminating the practitioner's representation — even if there would be no prejudice to the client.

    Rule 1.4 of the Model Rules of Professional Conduct is the widely-adopted basis for the duty of disclosure to clients.  Forty-nine of the fifty states have adopted versions of the Model Rules of Professional Conduct, along with the U.S. Patent and Trademark Office and four of the five U.S. territories.[1]

    The U.S. Patent and Trademark Office's version of Model Rule 1.4 reads:

    (a) A practitioner shall:
        (1) Promptly inform the client of any decision or circumstance with respect to which the client's informed consent is required by the USPTO Rules of Professional Conduct;
        (2) Reasonably consult with the client about the means by which the client's objectives are to be accomplished;
        (3) Keep the client reasonably informed about the status of the matter;
        (4) Promptly comply with reasonable requests for information from the client; and
        (5) Consult with the client about any relevant limitation on the practitioner's conduct when the practitioner knows that the client expects assistance not permitted by the USPTO Rules of Professional Conduct or other law.
    (b) A practitioner shall explain a matter to the extent reasonably necessary to permit the client to make informed decisions regarding the representation.

    37 C.F.R. § 11.104.  The obligation to disclose errors arises primarily out of sections (a)(1) and (a)(3), but also relies upon sections (a)(2) and (a)(4).  Specifically, a material error is the sort of information that forms an important part of the status of a case or matter and would lead the client to have to make informed decisions.  In light of those provisions, numerous states (both courts and bar associations) have found that an attorney has an obligation to disclose any errors that could cause prejudice to a client, underlie an ethics complaint, or give rise to a malpractice claim.

    The ABA found that the obligation of disclosure would go further, however.  Even if there is no prejudice to the client, it concluded that there would be a duty to disclose errors that an independent, disinterested attorney would believe would cause a reasonable client to lose confidence in the erring practitioner.  Notably, no jurisdiction has yet found such an obligation of disclosure, and the issue would not come up in the context of a malpractice case.  However, it could come up in the context of an ethics complaint, and the risk of non-disclosure (or covering up) a non-prejudicial error is likely greater than the cost of disclosing it with an explanation.

    In determining the scope of the obligation of disclosure, however, the ABA found a clear limit.  Namely, the obligation to disclose extends only to current clients.  Rule 1.4 describes the obligation of communication as relating to a "client," not to former clients.  As a result, if the error is not identified until after the representation ends — and the representation has been terminated in accordance with Rule 1.16 — there is no obligation to disclose an error.  There may be practical reasons, such as goodwill or business development, for such a disclosure, but there is no ethical obligation under this ABA opinion.

    Thus, the ABA has drawn a clear division between current and former clients with regard to the disclosure of errors.  For a current client, a practitioner must disclose errors that a reasonable, disinterested practitioner would believe (a) would be reasonably likely to harm or prejudice the client or (b) would reasonably cause the client to consider terminating the representation.  For former clients, as long as the representation has been properly terminated, there is no ethical duty to disclose any errors whatsoever.

    [1] California has not adopted the Model Rules, but has a provision analogous to Rule 1.4 in its rules.  Furthermore, the bar has proposed adoption of the Model Rules to the California Supreme Court.  The only territory that has not adopted the Model Rules is Puerto Rico.

  • Claims for Refreshing Phone Display Found Patent Eligible

    By James Korenchan —

    District Court for the Northern District of CaliforniaEarlier this month, the U.S. District Court for the Northern District of California ruled that claims related to refreshing a phone's display are patent eligible under 35 U.S.C. § 101.  In response to an infringement suit brought by Local Intelligence, LLC, Defendants HTC America, Inc. and HTC Corporation (collectively, "HTC") challenged the eligibility of the asserted patents in their motion to discuss.  The motion was denied, with the Court relying almost entirely on the recent Federal Circuit decision in Core Wireless Licensing S.A.R.L. v. LG Electronics, Inc. (Fed. Cir. 2018).

    The patents at issue in this case, U.S. Patent Nos. 8,903,067 (the '067 patent), 9,219,982 (the '982 patent), and 9,084,084 (the '084 patent), are in the same family and are related to "automatically refreshing a display screen of a telephone."  The specification, shared by each patent, states that users typically have to navigate through many different menus to access the numerous services that their phones provide, such as voice messaging, weather and traffic, transferring funds, and ordering merchandise.  Acknowledging that users often access certain services at the same times or locations on a repeating basis (or use some services more than others), the patents purport to improve the display of services by utilizing these types of user behavior.  In particular, the invention involves storing mappings between specific locations or times and certain "functions" that correspond to particular services.  For instance, the function of "home" could represent the location of the user's home and could be mapped to whichever services the user typically accesses at home.  Given these mappings, the invention automatically determines the current time or location and then refreshes the display with whichever services are mapped to the current time or location.

    Both parties agreed that the asserted patents contained minimal differences in their claims, and thus the Court analyzed the asserted claims collectively, using claim 1 of the '067 patent as a representative claim:

    1.  A telephone having a display panel; a datastore including at least one function, wherein the at least one function comprises information relating to a current location of a telephone and at least one other condition associated with a user of the telephone, wherein the at least one function is associated with at least one communication service; circuitry operable to connect the telephone to a location server to obtain a current location of the telephone; and a function selector programmable to refresh a screen on the display panel of the telephone to include at least one communication service associated with the function, based at least in part on a current location of the telephone.

    In its motion to dismiss, HTC argued that the asserted claims are directed to no more than providing communication information based on user location and other information and are thus comparable to the abstract claims in Intellectual Ventures I LLC v. Capital One Fin. Corp. (Fed. Cir. 2017), which involved tailoring web-based content based on a viewer's location and address.  HTC also argued that "tailoring information is a fundamental process that precedes the computer era, and the claims are not sufficiently specific to recite a specific solution."

    Local Intelligence responded by arguing that the claims are instead directed to "specific systems and methods that use a location server associated with a system such as a WiFi network (and not a positioning system like GPS) to obtain a phone's current location, and a phone's 'datastore' or memory (as opposed to a carrier's records), in order to provide and refresh location – relevant communication services on a phone's display as the phone's current location changes."  Thus, Local Intelligence contended that the claims provide a specific solution to problems that arise when "using location-based technology in conjunction with displaying particular communication services on a phone."

    But the Court was not quite satisfied with either party's interpretation.  Finding HTC's interpretation too broad and Local Intelligence's interpretation too narrow, the Court instead concluded that the claims were directed to refreshing location-relevant communication services on a phone's display by obtaining a current location from a location server, selecting communication services using logic in a database, and refreshing the display.

    Given this, the Court turned to step one of the Alice framework and confidently declared that the Federal Circuit's Core Wireless decision is controlling.  In particular, the Court stressed the similarities between the asserted claims and those in Core Wireless, stating that "Both relate to the computer technology of user interfaces.  . . .  Both purport to solve the same problem within the realm of user interfaces: limited display space on electronic devices with small screens.  . . .  And both claim a specific manner of solving this problem."  The Court continued, stating that both the asserted claims and those in Core Wireless recite specific manners of limiting information that is displayed.  The Court then reached its conclusion:

    As such, the claims at issue do more than simply state a result (i.e., display communication services according to current location); they also recite the way in which it is accomplished (i.e., using location retrieved from the location server and functions stored in the datastore).  Accordingly, because the specific improvement to the technology of user interfaces claimed in Core Wireless was not an abstract idea, the Court must conclude that the similarly specific improvement to user interfaces claimed here is also not an abstract idea.

    Before wrapping up its analysis, the Court specifically addressed some of HTC's contrary arguments.  First, the Court dismissed HTC's argument that the asserted patents did not identify a particular technological problem to solve.  (However, though the Court believed the patents aimed to solve the same limited display space problem as in Core Wireless, they made sure to note that "not every purported technological improvement is patent eligible.")  Next, the Court dismissed HTC's argument that the asserted claims were not as specific as those in Core Wireless, particularly emphasizing the "functions," "datastore," and "location server" claim limitations:

    The claims in Core Wireless and the claims at issue here accomplish specificity in different ways, but they both do so to substantially the same degree.  In Core Wireless, the claims at issue recited specific graphical characteristics of the improved user interface (e.g., an "application summary window" which must be "reached directly" from the main menu, which contains "data" which is "selectable to launch the respective application").  . . .  Here, the claims at issue recite specific implementation characteristics as to how the information to be displayed is limited for the small screen (e.g., using a "location server" to supply the current location and using "functions" stored in a "datastore" to determine which communication services should be selected).  . . .  As such, the claims of the Asserted Patents recite the solution with a similar level of specificity to the Core Wireless claims and cannot be distinguished on this basis.

    Finding the claims to be non-abstract, the Court proceeded no further.

    Local Intelligence, LLC v. HTC America, Inc. (N.D. Cal. 2018)
    Order Denying Motion to Dismiss by District Judge Edward J. Davila